Tao Fang, Jin Jiang, Wenhao Yu, Rongyang Li, Hui Tian. DARS2 promotes the occurrence of lung adenocarcinoma via the ERK/c-Myc signaling pathway.Thoracic cancer. 2023, 14 (36): 3511-3521
Ricardo Rubio-Sánchez, Rocío Ríos-Reina, Cristina Ubeda. Effect of chemotherapy on urinary volatile biomarkers for lung cancer by HS-SPME-GC-MS and chemometrics.Thoracic cancer. 2023, 14 (36): 3522-3529
Ye Chan An, Jong Hoon Kim, Jae Myung Noh, Kyung Mi Yang, You Jin Oh, Sung Goo Park, Hong Ryul Pyo, Ho Yun Lee. Quantification of diffuse parenchymal lung disease in non-small cell lung cancer patients with definitive concurrent chemoradiation therapy for predicting radiation pneumonitis.Thoracic cancer. 2023, 14 (36): 3530-3539
Shi-Di Tang, Hao Zi, Hua Tao, Qiao Huang, Xing-Pei Guo, Tong Deng, Fei Li. Secular trends of morbidity and mortality of thyroid cancer in five Asian countries from 1990 to 2019 and their predictions to 2035.Thoracic cancer. 2023, 14 (36): 3540-3548
Yang Du, Xiao-Yan Liu, Li Zhang. Combining immune-checkpoint inhibitors with tocilizumab to treat a lung adenocarcinoma patient with pre-existing polymyalgia rheumatica: A case report.Thoracic cancer. 2023, :
Hao Wei, Zhiying Yue, Jialong Han, Ping Chen, Ke Xie, Yu Sun, Jiang Zhu. Oral compound probiotic supplements can improve the quality of life for patients with lung cancer during chemotherapy: A randomized placebo-controlled study.Thoracic cancer. 2023, :
Kazuto Sugai, Kojiro Nakaoka, Rika Tobita, Shinji Kikuchi, Kei Inoue, Midori Enokido, Moriyuki Kiyoshima. A case of a shrunken multilocular mediastinal cyst that developed into thymic carcinoma with lung metastases 13 years later.Thoracic cancer. 2023, :
Fen Wang, Xianglong Pan, Teng Zhang, Yan Zhong, Chenglong Wang, Hai Li, Jun Wang, Lili Guo, Mei Yuan. Predicting visceral pleural invasion in lung adenocarcinoma presenting as part-solid density utilizing a nomogram model combined with radiomics and clinical features.Thoracic cancer. 2023, :